Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

LGBTQ+

- PMLiVE

Novartis’ Tasigna tops Glivec in long-term trial

Boost ahead of patent expiry for leukaemia drug

- PMLiVE

AZ donates Brixham lab to Plymouth University

Will create global research and education facility

- PMLiVE

Senior hires at Precision Health Media

New VP for ad sales, chief financial officer ad member of the board

- PMLiVE

Ketchum loses healthcare head

Amanda Sefton leaves to pursue “passion project” in wine trade

FDA reins in Google-backed genetics company 23andMe

Health-related genetic test service put on hold pending US regulatory review

- PMLiVE

MSD appoints new UK head

Mike Nally moves from Swedish division

- PMLiVE

Study highlights poor diabetes consultation

Less than a third of patients asked for input into their treatment plans

- PMLiVE

AZ wins EU approval for four-strain flu vaccine

Fluenz Tetra offers competition to GSK’s Influsplit Tetra/Fluarix Tetra

- PMLiVE

Auxilium’s Xiaflex cleared in US for erection disorder

FDA approval to treat Peyronie's disease

Pfizer’s Jonathan Emms to be ABPI president

Will take over from MSD's Deepak Khanna in April

Novartis building

Novartis myeloma drug clears phase III trial

Panobinostat on course to be first in new class of treatment for bone marrow cancer

What will pharma’s digital future look like?

Take our 5-minute survey and have your say on the shape of digital marketing in 2014

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links